Participant’s data including characteristics and primary outcome measurement. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Olfactory function test graphical summary and results. by Myeongguk Jeong (16386165)

Subjects:

Effects of BM-MSCs on different types of lung cell death in different group. by Chen Lu (135200)

Subjects:

Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

A schematic representation of how BM-MSCs reduce inflammation, oxidative stress, and cell death to alleviate decompression induced acute lung injury. by Chen Lu (135200)

Subjects:

Raw Data. by Chen Lu (135200)

Subjects:

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Subjects:

Immunohistochemical staining results for OMP in olfactory bulb. by Myeongguk Jeong (16386165)

Subjects:

The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels. by Qi He (384033)

Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in lipid peroxidation levels. by Qi He (384033)

Association between FF Proximity and BMI by sex. by Kimberly Yuin Y’ng Wong (22766265)

“…An exponential decrease in FF proximity was associated with 0.7 kg/m² (p < 0.001) increase in BMI among males and 0.4 kg/m² (p < 0.05) decrease among females. …”

Table 3_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

“…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”

Table 5_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

“…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”

Table 7_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

“…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”

Table 2_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.doc by Hua Ruan (195072)

“…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”

Table 1_PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis.docx by Hua Ruan (195072)

“…Background<p>Advanced triple-negative breast cancer (TNBC) presents significant therapeutic challenges, particularly in Asian populations, which exhibit distinct biological and genetic characteristics. …”